Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates
Sam Vasilevsky1, Milos Stojanov1, Gilbert Greub2
1a Materno-fetal and Obstetrics Research Unit ; Department of Obstetrics and Gynecology; Maternity; University Hospital ; Lausanne , Switzerland.
Abstract:
Pmps (Polymorphic Membrane Proteins) are a group of membrane bound surface exposed chlamydial proteins that have been characterized as autotransporter adhesins and are important in the initial phase of chlamydial infection. These proteins all contain conserved GGA (I, L, V) and FxxN tetrapeptide motifs in the N-terminal portion of each protein. All chlamydial species express Pmps. Even in the chlamydia-related bacteria Waddlia chondrophila, a Pmp-like adhesin has been identified, demonstrating the importance of Pmps in Chlamydiales biology. Chlamydial species vary in the number of pmp genes and their differentially regulated expression during the infectious cycle or in response to stress. Studies have also demonstrated that Pmps are able to induce innate immune functional responses in infected cells, including production of IL-8, IL-6 and MCP-1, by activating the transcription factor NF-κB. Human serum studies have indicated that although anti-Pmp specific antibodies are produced in response to a chlamydial infection, the response is variable depending on the Pmp protein. In C. trachomatis, PmpB, PmpC, PmpD and PmpI were the proteins eliciting the strongest immune response among adolescents with and without pelvic inflammatory disease (PID). In contrast, PmpA and PmpE elicited the weakest antibody response. Interestingly, there seems to be a gender bias for Pmp recognition with a stronger anti-Pmp reactivity in male patients. Furthermore, anti-PmpA antibodies might contribute to adverse pregnancy outcomes, at least among women with PID. In vitro studies indicated that dendritic cells infected with C. muridarum were able to present PmpG and PmpF on their MHC class II receptors and T cells were able to recognize the MHC class-II bound peptides. In addition, vaccination with PmpEFGH and Major Outer Membrane Protein (MOMP) significantly protected mice against a genital tract C. muridarum infection, suggesting that Pmps may be an important component of a multi-subunit chlamydial vaccine. Thus, Pmps might be important not only for the pathogenesis of chlamydial infection, but also as potential candidate vaccine proteins.
Insights
Polymorphic Membrane Proteins (Pmps) are crucial chlamydial adhesins involved in infection and immunity. Research shows Pmps are key targets for immune responses and potential vaccine candidates against chlamydial diseases.
Area of Science:
- Microbiology and Immunology
- Bacterial Pathogenesis
- Vaccine Development
Background:
- Polymorphic Membrane Proteins (Pmps) are surface-exposed chlamydial adhesins vital for initial infection.
- These proteins possess conserved N-terminal motifs (GGA and FxxN) and are present across all chlamydial species.
- Pmps can modulate host innate immunity by activating NF-κB, leading to cytokine production (IL-8, IL-6, MCP-1).
Purpose of the Study:
- To investigate the role of Polymorphic Membrane Proteins (Pmps) in chlamydial infection and host immune response.
- To evaluate the potential of Pmps as vaccine candidates against chlamydial infections.
Main Methods:
- Analysis of anti-Pmp antibody responses in human serum from patients with chlamydial infections.
- In vitro studies involving dendritic cell presentation of Pmp antigens (PmpG, PmpF) on MHC class II.
- Mouse vaccination studies using Pmps (PmpEFGH) and Major Outer Membrane Protein (MOMP) followed by challenge.
Main Results:
- Variable antibody responses to different Pmps were observed in humans; PmpB, PmpC, PmpD, and PmpI elicited stronger responses than PmpA and PmpE.
- A gender bias in Pmp recognition was noted, with stronger reactivity in males, and anti-PmpA antibodies linked to adverse pregnancy outcomes in PID patients.
- Vaccination with Pmps and MOMP conferred significant protection against genital tract infection in mice, indicating Pmp immunogenicity and protective potential.
Conclusions:
- Pmps are significant contributors to chlamydial pathogenesis and host immune evasion.
- Specific Pmps are immunogenic and can induce protective immunity, highlighting their potential as vaccine components.
- Pmps represent promising candidates for developing novel, multi-subunit chlamydial vaccines.
Related Concept Videos
Bacterial Phylum Chlamydiae
Regulation of Bacterial Virulence


